National cancer institute prostate cancer genetics workshop

Cancer Research

Volumn 71, Issue 10, 2011, Pages 3442-3446

  Catalona, William J ^a   Bailey Wilson, Joan E ^d   Camp, Nicola J ^c   Chanock, Stephen J ^f,g   Cooney, Kathleen A ^h   Easton, Douglas F ⁱ   Eeles, Rosalind A ^j   FitzGerald, Liesel M ^k   Freedman, Matthew L ^l,m   Gudmundsson, Julius ⁿ   Kittles, Rick A ^b   Margulies, Elliott H ^d   McGuire, Barry B ^a   Ostrander, Elaine A ^d   Rebbeck, Timothy R ^o   Stanford, Janet L ^k   Thibodeau, Stephen N ^p   Witte, John S ^q   Isaacs, William B ^e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e DEPARTMENT OF PATHOLOGY   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g SAIC FREDERICK INC   (United States)

^h UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^j INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^k UNIVERSITY OF WASHINGTON   (United States)

^l DANA FARBER CANCER INSTITUTE   (United States)

^m BROAD INSTITUTE OF MIT AND HARVARD   (United States)

ⁿ DECODE GENETICS   (Iceland)

^o UNIVERSITY OF PENNSYLVANIA   (United States)

^p MAYO CLINIC   (United States)

^q UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BIOINFORMATICS; BIOTECHNOLOGY; CANCER CENTER; CANCER GENETICS; CANCER GROWTH; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CONFERENCE PAPER; DISEASE ACTIVITY; DNA SEQUENCE; ETHNICITY; FAMILIAL CANCER; GENE FREQUENCY; GENE MAPPING; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HERITABILITY; HUMAN; HUMAN GENOME; MOLECULAR GENETICS; ONSET AGE; PATIENT CARE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; REFERENCE VALUE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; WORKSHOP;

COMPUTATIONAL BIOLOGY; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; NATIONAL CANCER INSTITUTE (U.S.); NATIONAL INSTITUTES OF HEALTH (U.S.); POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; SEQUENCE ANALYSIS, DNA; UNITED STATES;

EID: 79956068299     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-0314     Document Type: Conference Paper

References (11)

1. Penney KL, Pyne S, Schumacher FR, Sinnott JA, Mucci LA, Kraft PL, et al. Genome-wide association study of prostate cancer mortality. Cancer Epidemiol Biomarkers Prev 2010;19:2869-76.
2. Palanisamy N, Ateeq B, Kalyana-Sundaram S, Pflueger D, Ramnarayanan K, Shankar S, et al. Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nat Med 2010;16:793-8.
3. Witte JS, Goddard KA, Conti DV, Elston RC, Lin J, Suarez BK, et al. Genomewide scan for prostate cancer-aggressiveness loci. Am J Hum Genet 2000;67:92-9. (Pubitemid 30481547)
4. Stanford JL, McDonnell SK, Friedrichsen DM, Carlson EE, Kolb S, Deutsch K, et al. Prostate cancer and genetic susceptibility: a genome scan incorporating disease aggressiveness. Prostate 2006;66:317-25.
5. Mitra AV, Bancroft EK, Barbachano Y, Page EC, Foster CS, Jameson C, et al. Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int 2011;107:28-39.
6. Fitzgerald LM, Kwon EM, Koopmeiners JS, Salinas CA, Stanford JL, Ostrander EA. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features. Clin Cancer Res 2009;15:3231-7.
7. Cheng I, Plummer SJ, Neslund-Dludas C, Klein EA, Casey G, Rybicki BA, et al. Prostate cancer susceptibility variants confer increased risk of disease progression. Cancer Elpidemiol Biomarkers Prev 2010;19;2124-32.
8. Gudmundsson J, Besenbacher S, Sulem P, Budbjartsson DF, Olafsson I, Arinbjamarson S, et al. Genetic correction of PSA values using sequence variants associated with PSA levels. Sci Transl Med 2010;2:62ra92.
9. Witte JS. Personalized prostate cancer screening: improving PSA tests with genomic information. Sci Transl Med 2010;2:62.
10. Schaid DJ, McDonnell SK, Zarfas KE, Cunningham JM, Hebbring S, Thibodeau SN, et al. Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet 2006;120:471-85. (Pubitemid 44669782)
11. Johanneson B, McDonnell SK, Karyadi DM, Quignon P, McIntosh L, Riska SM, et al. Family-based association analysis of 42 hereditary prostate cancer families identifies the apolipoprotein L3 region on chromosome 22q12 as a risk locus. Hum Mol Genet 2010;19:3852-62.